No Data
No Data
CNS Pharmaceuticals Reports Cash Position of $14M as of February 26
Express News | CNS Pharmaceuticals Announces Plans For TPI 287 Clinical Program Launch By Year-End; Primary Data Analysis For Berubicin Expected In H1 2025
CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing
Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
CNS Pharmaceuticals Inc Trading Halted, News Pending
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Unlock the Full List
YouvsYou : 5